133 related articles for article (PubMed ID: 37144852)
1. Total marrow lymphoid irradiation and cyclophosphamide is associated with low toxicity and good outcomes in patients undergoing hematopoietic stem cell transplantation for acute lymphoblastic leukemia and chronic myeloid leukemia in lymphoid blast crises - A phase I study.
George B; Balakrishnan R; S P; Lionel S; Selvarajan S; Devasia AJ; Korula A; Lakshmi KM; Aboobacker FN; Kulkarni U; Godson HF; Raj JS; Abraham A; Backianathan S; Mathews V
Clin Transplant; 2023 Sep; 37(9):e15010. PubMed ID: 37144852
[TBL] [Abstract][Full Text] [Related]
2. Phase I Trial of Total Marrow and Lymphoid Irradiation Transplantation Conditioning in Patients with Relapsed/Refractory Acute Leukemia.
Stein A; Palmer J; Tsai NC; Al Malki MM; Aldoss I; Ali H; Aribi A; Farol L; Karanes C; Khaled S; Liu A; O'Donnell M; Parker P; Pawlowska A; Pullarkat V; Radany E; Rosenthal J; Sahebi F; Salhotra A; Sanchez JF; Schultheiss T; Spielberger R; Thomas SH; Snyder D; Nakamura R; Marcucci G; Forman SJ; Wong J
Biol Blood Marrow Transplant; 2017 Apr; 23(4):618-624. PubMed ID: 28087456
[TBL] [Abstract][Full Text] [Related]
3. Extramedullary relapse following total marrow and lymphoid irradiation in patients undergoing allogeneic hematopoietic cell transplantation.
Kim JH; Stein A; Tsai N; Schultheiss TE; Palmer J; Liu A; Rosenthal J; Forman SJ; Wong JY
Int J Radiat Oncol Biol Phys; 2014 May; 89(1):75-81. PubMed ID: 24725691
[TBL] [Abstract][Full Text] [Related]
4. Phase I trial of myeloablative conditioning with 3-day total marrow and lymphoid irradiation for leukemia.
Ogawa H; Konishi T; Najima Y; Kito S; Hashimoto S; Kato C; Sakai S; Kanbara Y; Atsuta Y; Konuma R; Wada A; Murakami D; Nakasima S; Uchibori Y; Onai D; Hamamura A; Nishijima A; Shingai N; Toya T; Shimizu H; Kobayashi T; Ohashi K; Doki N; Murofushi KN
Cancer Sci; 2023 Feb; 114(2):596-605. PubMed ID: 36221800
[TBL] [Abstract][Full Text] [Related]
5. Total Body Irradiation-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors.
Solomon SR; Sizemore CA; Sanacore M; Zhang X; Brown S; Holland HK; Morris LE; Bashey A
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1299-307. PubMed ID: 25797174
[TBL] [Abstract][Full Text] [Related]
6. Total Marrow and Lymphoid Irradiation with Post-Transplantation Cyclophosphamide for Patients with AML in Remission.
Stein AS; Al Malki MM; Yang D; Palmer JM; Tsai NC; Aldoss I; Ali H; Aribi A; Artz A; Dandapani S; Farol L; Hui S; Liu A; Nakamura R; Pullarkat V; Radany E; Rosenthal J; Salhotra A; Sanchez JF; Spielberger R; Marcucci G; Forman SJ; Wong J
Transplant Cell Ther; 2022 Jul; 28(7):368.e1-368.e7. PubMed ID: 35398328
[TBL] [Abstract][Full Text] [Related]
7. Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia.
Shigematsu A; Kondo T; Yamamoto S; Sugita J; Onozawa M; Kahata K; Endo T; Shiratori S; Ota S; Obara M; Wakasa K; Takahata M; Takeda Y; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M
Biol Blood Marrow Transplant; 2008 May; 14(5):568-75. PubMed ID: 18410899
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
9. Comparing the outcomes between TMLI and non-TMLI conditioning regimens for adult high-risk acute lymphoblastic leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: a single-center experience.
Zhao X; Lu X; Tang L; Yan H; Chen W; Shi W; Zhong Z; You Y; Xia L; Hu Y; Wang H
Leuk Lymphoma; 2020 Dec; 61(12):2859-2867. PubMed ID: 32654551
[TBL] [Abstract][Full Text] [Related]
10. A Comparison of the Myeloablative Conditioning Regimen Fludarabine/Busulfan with Cyclophosphamide/Total Body Irradiation, for Allogeneic Stem Cell Transplantation in the Modern Era: A Cohort Analysis.
Gooptu M; Kim HT; Ho VT; Alyea EP; Koreth J; Armand P; Ritz J; Nikiforow S; Glotzbecker BE; Nageshwar P; Soiffer RJ; Antin JH; Cutler CS
Biol Blood Marrow Transplant; 2018 Aug; 24(8):1733-1740. PubMed ID: 29555313
[TBL] [Abstract][Full Text] [Related]
11. Nonmyeloablative Conditioning Regimen Including Low-Dose Total Marrow/Lymphoid Irradiation Before Haploidentical Transplantation with Post-Transplantation Cyclophosphamide in Patients with Advanced Lymphoproliferative Diseases.
Sarina B; Mancosu P; Navarria P; Bramanti S; Mariotti J; De Philippis C; Clerici E; Franzese C; Mannina D; Valli V; Carlo-Stella C; Scorsetti M; Santoro A; Castagna L
Transplant Cell Ther; 2021 Jun; 27(6):492.e1-492.e6. PubMed ID: 33857448
[TBL] [Abstract][Full Text] [Related]
12. Total Marrow Irradiation for Second Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Advanced Acute Leukemia.
Dominietto A; Vagge S; di Grazia C; Bregante S; Raiola AM; Varaldo R; Gualandi F; Gusinu M; Barra S; Agostinelli S; Angelucci E; Hui S
Transplant Cell Ther; 2023 Aug; 29(8):506.e1-506.e6. PubMed ID: 37094701
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.
Gürman G; Arat M; Ilhan O; Konuk N; Beksaç M; Celebi H; Ozcan M; Arslan O; Ustün C; Akan H; Uysal A; Koç H
Cytotherapy; 2001; 3(4):253-60. PubMed ID: 12171713
[TBL] [Abstract][Full Text] [Related]
14. [Clinical outcome of allogeneic hematopoietic stem cell transplantation with FLAG sequential busulfan/cyclophosphamide conditioning regimen for refractory/relapsed acute myeloid leukemia].
Liu W; Li Y; Qiu ZX; Yin Y; Sun YH; Xu WL; Wang Q; Liang ZY; Dong YJ; Wang LH; Cen QN; Wang MJ; Wang WS; Ou JP; Ren HY
Zhonghua Nei Ke Za Zhi; 2018 Aug; 57(8):576-581. PubMed ID: 30060329
[No Abstract] [Full Text] [Related]
15. Fludarabine versus cyclophospamide in combination with myeloablative total body irradiation as conditioning for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Giebel S; Labopin M; Schroeder T; Swoboda R; Maertens J; Bourhis JH; Grillo G; Salmenniemi U; Hilgendorf I; Kröger N; Poiré X; Cornelissen JJ; Arat M; Savani B; Spyridonidis A; Nagler A; Mohty M
Am J Hematol; 2023 Apr; 98(4):580-587. PubMed ID: 36626592
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of haploidentical peripheral stem cell transplantation with combination of post-transplant cyclophosphamide (PTCy) and anti-thymocyte globulin (ATG) compared to unrelated donor transplantation in acute myeloid leukemia: A retrospective 10-year experience.
Barkhordar M; Kasaeian A; Janbabai G; Mousavi SA; Fumani HK; Tavakoli S; Bahri T; Ghavamzadeh A; Vaezi M
Leuk Res; 2022 Sep; 120():106918. PubMed ID: 35843087
[TBL] [Abstract][Full Text] [Related]
17. Impact of Conditioning Regimen on Outcomes for Children with Acute Myeloid Leukemia Undergoing Transplantation in First Complete Remission. An Analysis on Behalf of the Pediatric Disease Working Party of the European Group for Blood and Marrow Transplantation.
Lucchini G; Labopin M; Beohou E; Dalissier A; Dalle JH; Cornish J; Zecca M; Samarasinghe S; Gibson B; Locatelli F; Bertrand Y; Abdel-Rahman F; Socie G; Sundin M; Lankester A; Sedlacek P; Hamladji RM; Heilmann C; Afanasyev B; Hough R; Peters C; Bader P; Veys P
Biol Blood Marrow Transplant; 2017 Mar; 23(3):467-474. PubMed ID: 27916512
[TBL] [Abstract][Full Text] [Related]
18. HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase.
Xiao-Jun H; Lan-Ping X; Kai-Yan L; Dai-Hong L; Huan C; Wei H; Yu-Hong C; Jing-Zhi W; Yao C; Xiao-Hui Z; Hong-Xia S; Dao-Pei L
Ann Med; 2008; 40(6):444-55. PubMed ID: 18608121
[TBL] [Abstract][Full Text] [Related]
19. Fludarabine or cyclophosphamide in combination with total body irradiation as myeloablative conditioning prior to allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia: an analysis by the Acute Leukemia Working Party of the EBMT.
Giebel S; Labopin M; Socié G; Aljurf M; Salmenniemi U; Labussière-Wallet H; Srour M; Kröger N; Zahrani MA; Lioure B; Reményi P; Arat M; Bourhis JH; Helbig G; Tbakhi A; Forcade E; Huynh A; Brissot E; Spirydonidis A; Savani BN; Peric Z; Nagler A; Mohty M
Bone Marrow Transplant; 2023 May; 58(5):506-513. PubMed ID: 36725978
[TBL] [Abstract][Full Text] [Related]
20. Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Nagler A; Labopin M; Houhou M; Aljurf M; Mousavi A; Hamladji RM; Al Zahrani M; Bondarenko S; Arat M; Angelucci E; Koc Y; Gülbas Z; Sica S; Bourhis JH; Canaani J; Brissot E; Giebel S; Mohty M
J Hematol Oncol; 2021 Apr; 14(1):53. PubMed ID: 33794963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
